Researchers have crunched data on excess deaths and calculated that Canada’s 2023 wildfire season shortened the lives of ...

A major study of laser correction for short-sightedness shows that the procedure is as safe and effective in older teenagers as it is in adults, according to research presented at the 43rd Congress of ...

A more precise form of noninvasive brain stimulation, tailored to an individual’s brain structure, may offer a faster and more effective path to relief for people with moderate to major depression. A ...

When suppressing barking, such as through the use of shock, we risk silencing the symptom without addressing the dog’s underlying emotions. By using anti-bark collars we may therefore cause a dog’s ...

Tirzepatide is more cost-effective than semaglutide for knee osteoarthritis and obesity, optimizing resources for patients not seeking surgical options, which remain cost-effective for those eligible.

In two new studies, scientists at Oregon Health & Science University have uncovered detailed blueprints of how certain molecular "gates" in human cells work—findings that could open doors to new ...

The eye drops substantially reduced patients' dependence on reading glasses, reported Giovanna Benozzi, MD, of the Center for Advanced Research for Presbyopia in Buenos Aires, Argentina, at the ...

CNX Resources (CNX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

Every step taken during the Rocky Mountain Walk to End Alzheimer’s on Saturday at Brush Creek Park in Eagle brings us closer to a world without Alzheimer’s disease. This annual event unites ...

Analysis led by Mass General Brigham researchers shows tirzepatide offers greater value than semaglutide for most patients• For eligible and willing ...

Struggling with the constant buzz of tinnitus or the frustration of hearing loss? You’re not alone and you’re not without hope. More than 50 million Americans ...

Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a series of antibodies and find that some work, while others do not.